Concepedia

Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience

Yasir Bashir, Sajjad Geelani, Nusrat Bashir, S Mir, Mosin Mushtaq, Mohammed A Jan, Javid Rasool

South Asian Journal of Cancer · 2015 · 10 citations · 21 references

DOIFull text

Open access

Abstract

Low dose cytarabine is effective treatment option for elderly patients with AML when standard treatment options are not warranted.

References

21

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Bruce D. Cheson, John M. Bennett, Thomas Büchner et al. · Journal of Clinical Oncology · 2003 · 2.6K citations

, , +18

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Gunnar Juliusson, Petar Antunović, Åsa Rangert Derolf et al. · Blood · 2008 · 983 citations

Anthracycline Dose Intensification in Acute Myeloid Leukemia

Hugo F. Fernández, Zhuoxin Sun, Xiaopan Yao et al. · New England Journal of Medicine · 2009 · 900 citations · Full text

A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment

Alan K. Burnett, Donald Milligan, Archie Prentice et al. · Cancer · 2007 · 613 citations · Full text

Cytarabine Dose for Acute Myeloid Leukemia

Bob Löwenberg, Thomas Pabst, Edo Vellenga et al. · New England Journal of Medicine · 2011 · 405 citations · Full text